Mobile Menu

News

Years

Categories

Media Inquiries

Drew Hoffman

dhoffman@echo.global

and/or marketing@echo.global

405.279.6664

December 7, 2021

Zeno Technologies Creates Pioneer Customer Program for Energy Businesses Ready to Run on Real-Time Insights

Zeno Technologies today unveiled its new Pioneer customer program to partner with trailblazing organizations to help build a more trusted future for the energy industry by enabling smarter decisions through data-driven business insight. The program – specially designed for businesses eager to embrace new technologies – will offer up to 10 companies a curated package of Pioneer benefits, including early access to new product features, enhanced customer support, C-level engagement with Zeno’s leadership team, direct input into product development, and special networking opportunities for virtual & in-person collaboration with fellow energy industry Pioneers.

Read More

November 16, 2021

Deka Biosciences Raises USD 20 Million in Series A Financing

Maryland-based biotech company Deka Biosciences ("Deka") today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and new investor Lumira Ventures. Additional investors include O-Bio (Echo Investment Capital), Viva BioInnovator, and Alexandria Venture Investments.

Read More

October 21, 2021

Zeno Technologies Unveils a New Platform to Help Energy Companies Thrive in the Production Era

Zeno Technologies today unveiled a new cloud-based platform to help energy companies, investors and partners adapt and thrive in the face of new market realities in the Production Era. The energy industry is fundamentally different than it was just a few short years ago, and today’s energy-focused organizations need a set of modern tools to unlock data to inform smarter, faster business decisions. Zeno’s new Energy Operating System provides the clarity to understand and improve business performance, and the insight to decisively assess and pursue new investment opportunities.

Read More

July 21, 2021

Alloy Therapeutics and Echo Investment Capital Create Wheeler Bio to Accelerate the Development of New Antibody Therapeutics

Alloy Therapeutics and Echo Investment Capital today announced the formation of Wheeler Bio, a new biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact. Wheeler’s comprehensive discovery-to-IND programs are designed to provide emerging biopharma companies a faster and more predictable path to the clinic.

Read More

July 18, 2021

New drug manufacturer, hotel to anchor $240 million OKC innovation district development

A start-up pharmaceutical manufacturer with a reported potential to employ thousands is set to anchor a $240 million mixed-use development being built next year at the gateway to Oklahoma City’s innovation district.

Read More

Let’s build something great together.